# A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

> **NCT01169714** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 0.1 mg PF-04995274
- **DRUG:** 1 mg PF-04995274
- **DRUG:** 10 mg PF-04995274
- **DRUG:** 15 mg PF-04995274
- **DRUG:** 1.0 mg PF-04995274
- **DRUG:** 15 mg PF-04995274

## Key facts

- **NCT ID:** NCT01169714
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169714, "A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01169714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*